Literature DB >> 1870365

[Initial results of image cytometric DNA analysis in the evaluation of prognosis in papillary thyroid cancer].

T Böttger1, H Gabbert, M Stöckle, B Schernos, T Junginger.   

Abstract

In this study we analysed DNA-ploidy as a potential prognostic parameter in papillary thyroid carcinoma. Paraffin embedded histological material, obtained by resection from 19 patients with a papillary thyroid carcinoma, was selected for analysis. Tumor areas within the paraffin-embedded material were identified by HE-stained reference sections. One 50 microns section was dewaxed, rehydrated and mechanically and enzymatically prepared to form a suspension of 10,000 cells/ml. 1 ml of the suspension, which contained bare nuclei with small rests of cytoplasma, was centrifuged on glass slides. The fixed nuclei were air-dried and stained by Feulgen SITS technique, which allows for the quantitative measurement of DNA. The DNA analysis was carried out with a computer-controlled single-cell cytophotometry. In contrast to using flow cytometry, only the tumor cells were measured by image-cytometry. Overlapping nuclei, dirt and other artifacts as well as inflammatory cells were efficiently eliminated. With DNA image-cytometry, we could differentiate between diploid (n = 13) and aneuploid (n = 6) tumors. Best prognosis with a survival rate of 92% after 103 months had patients with diploid tumors in contrast to patients with aneuploid tumors who did not survive more than 72 months.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870365     DOI: 10.1007/bf00250341

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  22 in total

1.  Potential prognostic significance of cytometrically determined DNA abnormality in GI tract human tumors.

Authors:  L Teodori; D Tirindelli-Danesi; E Cordelli; R Uccelli; R De Vita; M Spano; F Mauro; A Schillaci; A Moraldi; L Capurso
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

2.  Statistical evaluation of the prognostic value of nuclear DNA content in papillary, follicular, and medullary thyroid tumors.

Authors:  M Bäckdahl; J Carstensen; G Auer; E Tallroth
Journal:  World J Surg       Date:  1986-12       Impact factor: 3.352

3.  Iterative image transformations for an automatic screening of cervical smears.

Authors:  F Meyer
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

4.  Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas.

Authors:  K Sasaki; T Hashimoto; K Kawachino; M Takahashi
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

5.  Preparation of monolayer smears from paraffin-embedded tissue for image cytometry.

Authors:  A M van Driel-Kulker; W E Mesker; I van Velzen; H J Tanke; J Feichtinger; J S Ploem
Journal:  Cytometry       Date:  1985-05

6.  Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects.

Authors:  S O Emdin; R Stenling; G Roos
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

7.  Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.

Authors:  I D Hay; C S Grant; W F Taylor; W M McConahey
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

8.  Flow cytometric analysis of nuclear DNA content in esophageal cancer. Aneuploidy as an index for highly malignant potential.

Authors:  K Kaketani; T Saito; M Kobayashi
Journal:  Cancer       Date:  1989-08-15       Impact factor: 6.860

9.  Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age.

Authors:  F Bacourt; B Asselain; J C Savoie; E D'Hubert; J P Massin; G Doucet; A Leger; H Garnier
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

10.  Further evidence of the validity of risk group definition in differentiated thyroid carcinoma.

Authors:  B Cady; R Rossi; M Silverman; M Wool
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.